Processing of carbamazepine PEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterisation, and in vitro dissolution

被引:130
作者
Moneghini, M
Kikic, I
Voinovich, D
Perissutti, B
Filipovic-Grcic, J
机构
[1] Univ Trieste, Dept Pharmaceut Sci, I-34127 Trieste, Italy
[2] Univ Trieste, Dept Chem Environm & Raw Mat Engn, I-34127 Trieste, Italy
[3] Univ Zagreb, Fac Pharm & Biochem, Dept Pharmaceut, Zagreb 10000, Croatia
关键词
gas antisolvent crystallisation; supercritical fluids; solid dispersions; carbamazepine; PEG; 4000; physico-chemical characterisation;
D O I
10.1016/S0378-5173(01)00711-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to apply the attractive technique of the supercritical fluid to the preparation of solvent-free solid dispersions. In particular, the gas antisolvent crystallisation technique (GAS), using supercritical carbon dioxide as processing medium, has been considered to prepare an enhanced release dosage form for of the poorly soluble carbamazepine, employing PEG 4000 as a hydrophilic carrier. The physical characterisation of the systems using laser granulometer, powder X-ray diffraction, thermal analyses, and scanning electron microscopy was carried out: in order to understand the influence of this technological process on the physical status of the drug. The results of the physical characterisation attested a substantial correspondence of the solid stale of the drug before and after treatment with GAS technique, whereas a pronounced change in size and morphology of the drug crystals was noticed. The dramatic reduction of the dimensions and the better crystal shape, together with the presence of the hydrophilic polymer determined a remarkable enhancement of the in vitro drug dissolution rate. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:129 / 138
页数:10
相关论文
共 32 条
[1]   Fractional crystallization by gas antisolvent technique: Theory and experiments [J].
Bertucco, A ;
Lora, M ;
Kikic, I .
AICHE JOURNAL, 1998, 44 (10) :2149-2158
[2]  
BLOCH DW, 1987, PHARM ACTA HELV, V62, P23
[3]   POLYETHYELENE GLYCOLS AND DRUG RELEASE [J].
CRAIG, DQM .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1990, 16 (17) :2501-2526
[4]   HIGH-PRESSURE PHASE-EQUILIBRIA OF POLY(ETHYLENE GLYCOL) CARBON-DIOXIDE SYSTEMS [J].
DANESHVAR, M ;
KIM, S ;
GULARI, E .
JOURNAL OF PHYSICAL CHEMISTRY, 1990, 94 (05) :2124-2128
[5]   PREFORMULATION STUDIES ON SOLID DISPERSIONS CONTAINING TRIAMTERENE OR TEMAZEPAM IN POLYETHYLENE GLYCOLS OR GELUCIRE 44 14 FOR LIQUID FILLING OF HARD GELATIN CAPSULES [J].
DORDUNOO, SK ;
FORD, JL ;
RUBINSTEIN, MH .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (12) :1685-1713
[6]   Carbamazepine and polyethylene glycol solid dispersions: Preparation, in vitro dissolution, and characterization [J].
Doshi, DH ;
Ravis, WR ;
Betageri, GV .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (12) :1167-1176
[7]  
GALLAGHER PM, 1989, ACS SYM SER, V406, P334
[8]   A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in DL-PLG microparticles using supercritical fluids [J].
Ghaderi, R ;
Artursson, P ;
Carlfors, J .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 10 (01) :1-9
[9]  
Giunchedi P, 1990, Boll Chim Farm, V129, P17
[10]   Solubility parameters as predictors of miscibility in solid dispersions [J].
Greenhalgh, DJ ;
Williams, AC ;
Timmins, P ;
York, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (11) :1182-1190